在患有慢性阻塞性肺部疾病的成年人中,情绪调节困难和吸烟行为
Mary J Schadegg1, Laura J Dixon2, Aaron A Lee3
1Department of Psychiatry, NYU Grossman School of Medicine, One Park Ave, New York, NY, 10016, USA.
The Psychiatric quarterly
|July 15, 2024
概括
情绪调节 (ER) 的困难与慢性阻塞性肺病 (COPD) 的成年人当前吸烟的几率更高有关. 解决ER可能有助于COPD患者戒烟的努力.
科学领域:
- 肺部病理学 肺部病理学
- 精神病学是一个精神病学.
- 行为科学 行为科学
背景情况:
- 慢性阻塞性肺病 (COPD) 是美国死亡和残疾的主要原因.
- 戒烟对于COPD管理至关重要,但仍然具有挑战性.
- 情绪调节 (ER) 困难可能是COPD成年人持续吸烟行为的基础.
研究的目的:
- 研究COPD成年人的情绪调节困难和吸烟状态之间的关联.
- 检查ER困难与COPD患者每天吸烟的香烟数量之间的关系.
主要方法:
- 对320名被诊断患有COPD的成年人进行横截面研究.
- 参与者完成了吸烟状态,每日吸烟量和情绪调节困难 (情绪调节困难量表) 的自我报告措施.
- 根据年龄,性别,抑郁症,焦虑症和呼吸障碍严重程度调整的统计分析.
主要成果:
- 情绪调节中的更高难度 情绪调节量表得分与目前吸烟的可能性更高有关.
- 情绪调节的大多数维度,除了冲动性,与当前的吸烟状况有显著的联系.
- 情绪意识更大的困难与每天吸烟的香烟数量相关,但总的ER分数并不能预测每天吸烟的消费.
结论:
- 初步证据表明,COPD成年人的情绪调节困难和吸烟行为之间存在联系.
- 情绪调节可能是为COPD患者开发有效的戒烟干预措施的潜在目标.
- 需要进一步的研究来证实这些发现,并探索针对ER的治疗潜力.
相关概念视频
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:26Stress Prevention and Stress Management Techniques IV
28
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
28
01:26COPD: Management Using Bronchodilators and Corticosteroids
194
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
194